G protein-coupled receptor

δ-opioid receptor

Delta opioid receptor

The δ-opioid receptor was cloned by expression from the NG108-15 cell line. It has the structure of a G protein-coupled receptor, and in cells it showed the binding profile of the native δ receptor.1

Autoradiography in the rat showed that delta binding is restricted to a few areas, among them the anterior cingulate cortex, the neocortex, the amygdala, the olfactory tubercle, the nucleus accumbens and the caudate putamen. The mRNA of the receptor differs from those of the mu and kappa receptors and is found in the olfactory bulb, the allo- and neocortex, the caudate-putamen, the nucleus accumbens, the olfactory tubercle, the ventromedial hypothalamus, the hippocampus, the amygdala, the red nucleus, the pontine nuclei, the spinal cord and the dorsal root ganglia.2,3

The receptor is broadly expressed in the brain, binds endogenous opioid peptides and has a functional profile that is highly distinct from those of the mu and kappa receptors. Beneficial effects of DOR agonists are well established for emotional responses and mood disorders, and blocking the receptor increased anxiety-related behaviour in mice and rats. Activation of the receptor also regulates drug reward, inhibitory controls and learning, but whether delta compounds could treat drug abuse remains open.4

Mice without it show more anxiety-like and depression-like behaviour, the opposite of mice without the μ receptor.5

Delta receptors are a promising target for new analgesics. Novel delta agonists with potent analgesic properties and mouse models with mutations in the delta receptor gene have improved the knowledge of the role of the receptor in pain control. The regulation of the receptor at the cellular level affects its pain-reducing activity.6 Delta agonists can also cause convulsions. The agonists BW373U86 and SNC80 failed to produce convulsive behaviour in mice lacking the receptor, which shows that the receptor is absolutely involved. In normal mice BW373U86 produced both antinociception and convulsive activity through the same type of receptor, but the receptor reserve for the convulsions is greater than for the antinociception. A review adds that the epileptogenic effects of delta agonists appear to depend on the drug.7,4

Sources (7)
  1. Kieffer et al. 1992Kieffer BL, Befort K, Gaveriaux-Ruff C, et al. (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization Proc Natl Acad Sci U S A
  2. Mansour et al. 1987Mansour A, Khachaturian H, Lewis ME, et al. (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain J Neurosci
  3. Mansour et al. 1994Mansour A, Fox CA, Burke S, et al. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study J Comp Neurol
  4. Chu Sin Chung et al. 2013Chu Sin Chung P, Kieffer BL (2013) Delta opioid receptors in brain function and diseases Pharmacol Ther
  5. Filliol et al. 2000Filliol D, Ghozland S, Chluba J, et al. (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses Nat Genet
  6. Gavériaux-Ruff et al. 2011Gavériaux-Ruff C, Kieffer BL (2011) Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches Behav Pharmacol
  7. Broom et al. 2002Broom DC, Nitsche JF, Pintar JE, et al. (2002) Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice J Pharmacol Exp Ther

Binding affinity (Kᵢ)

12 substances, 19 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

7 measurements
  • BuprenorphineAntagonist4.5 nMToll et al. 1998 · 2 reports
    Assay
    human DOR in CHO cells, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Range
    1.5–4.5 nM in 2 reports
    Error
    ± 0.40 SD
    Sources and values behind the range, same assay family
    ReportValueWhere
    Toll et al. 19984.5 nMTable 5
    Obeng et al. 20211.5 nMTable 2
  • Hydromorphone38 nMWentland et al. 2009
    Assay
    CHO cell membranes expressing the human DOR, [3H]naltrindole displacement
    Shown value from
    Wentland et al. 2009, Table 1
  • MethadoneAgonist132 nMToll et al. 1998
    Assay
    human DOR in CHO cells, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Error
    ± 11 SD
  • MorphineAgonist140 nMNeumeyer et al. 2012 · 3 reports
    Assay
    CHO cells expressing human DOR, [3H]naltrindole competition
    Shown value from
    Neumeyer et al. 2012, Table 2
    Range
    140–250 nM in 3 reports
    Error
    ± 18 SEM
    Sources and values behind the range, same assay family
    ReportValueWhere
    Neumeyer et al. 2012140 nMTable 2
    Toll et al. 1998140 nMTable 5
    Obeng et al. 2021250 nMTable 2
  • FentanylAgonistunresolved153 nMToll et al. 1998 · 2 reports
    Assay
    human DOR in CHO cells, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Range
    153–539 nM in 2 reports
    Error
    ± 38 SD

    Reported values disagree and no value is established. 2 reports in all, 153–539 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Toll et al. 1998153 nMTable 5
    Obeng et al. 2021539 nMTable 2
  • 7-HydroxymitragynineAgonist219 nMKruegel et al. 2016 · 2 reports
    Assay
    cells expressing human DOR, opioid receptor binding
    Shown value from
    Kruegel et al. 2016, Table 2
    Range
    219–243 nM in 2 reports
    Error
    ± 41 SEM
    Sources and values behind the range, same assay family
    ReportValueWhere
    Obeng et al. 2021243 nMTable 2
    Kruegel et al. 2016219 nMTable 2
  • Mitragynine6800 nMObeng et al. 2021
    Assay
    CHO cells expressing hDOR, [3H]DADLE competition
    Shown value from
    Obeng et al. 2021, Table 2

Guinea pig

4 measurements
  • BuprenorphineAntagonist1.6 nMToll et al. 1998
    Assay
    guinea-pig brain membranes, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Error
    ± 0.07 SD
  • MethadoneAgonist37 nMToll et al. 1998
    Assay
    guinea-pig brain membranes, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Error
    ± 2.3 SD
  • MorphineAgonist50 nMToll et al. 1998
    Assay
    guinea-pig brain membranes, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Error
    ± 0.60 SD
  • FentanylAgonist74 nMToll et al. 1998
    Assay
    guinea-pig brain membranes, [3H]Cl-DPDPE competition
    Shown value from
    Toll et al. 1998, Table 5
    Error
    ± 3.5 SD

Mouse

1 measurement
  • BuprenorphineAntagonist0.42 nMHuang et al. 2001
    Assay
    recombinant mouse DOR in CHO membranes, [3H]diprenorphine competition
    Shown value from
    Huang et al. 2001, Table 1
    Error
    ± 0.04 SEM, n = 4

Rat

6 measurements
  • OxymorphoneAgonist81 nMBen Haddou et al. 2014
    Assay
    native rat brain membranes, [3H][Ile5,6]deltorphin II competition
    Shown value from
    Ben Haddou et al. 2014, Table 1
    Error
    ± 5.5 SEM
  • MorphineAgonist217 nMBen Haddou et al. 2014 · 2 reports
    Assay
    native rat brain membranes, [3H][Ile5,6]deltorphin II competition
    Shown value from
    Ben Haddou et al. 2014, Table 1
    Range
    80–217 nM in 2 reports
    Error
    ± 19 SEM
    Sources and values behind the range, same assay family
    ReportValueWhere
    Ben Haddou et al. 2014217 nMTable 1
    Tzschentke et al. 200780 nMTable 1
  • Oxycodone958 nMMonory et al. 1999
    Assay
    rat brain membranes, displacement of [3H]naltrindole
    Shown value from
    Monory et al. 1999, Table II
  • TapentadolAgonist970 nMTzschentke et al. 2007
    Assay
    rat opioid receptor binding assay
    Shown value from
    Tzschentke et al. 2007, Table 1
    Error
    ± 10 SEM
  • 3-HO-PCP2300 nMItzhak et al. 1981
    Assay
    rat brain homogenate (minus cerebellum), [3H]leucine-enkephalin 1.0 nM, delta site
    Shown value from
    Itzhak et al. 1981, Table 1B
  • CodeineAgonist5500 nMTzschentke et al. 2007
    Assay
    rat opioid receptor binding assay
    Shown value from
    Tzschentke et al. 2007, Table 1
    Error
    ± 600 SEM

Unspecified

1 measurement
  • Mitragyninesource not traced2250 nMLydecker et al. 2016
    Assay
    DOR opioid receptor binding, quoted in a review table (original assay not restated)
    Shown value from
    Lydecker et al. 2016, Table 1

Functional potency (EC₅₀)

5 substances, 5 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.

Human

4 measurements
  • OxymorphoneAgonist259 nMBen Haddou et al. 2014
    Assay
    CHO cells expressing human opioid receptor, [35S]GTPγS functional assay
    Shown value from
    Ben Haddou et al. 2014, Table 2
    Error
    ± 33 SEM
    Emax
    87.0 ± 40.0%
  • FentanylAgonist515 nMToll et al. 1998
    Assay
    human DOR-CHO cell membranes, [35S]GTPgammaS binding
    Shown value from
    Toll et al. 1998, Table 7
    Error
    ± 102 SD
    Emax
    86.0 ± 19.0%
  • MorphineAgonist668 nMBen Haddou et al. 2014 · 2 reports
    Assay
    CHO cells expressing human opioid receptor, [35S]GTPγS functional assay
    Shown value from
    Ben Haddou et al. 2014, Table 2
    Range
    317–668 nM in 2 reports
    Error
    ± 65 SEM
    Emax
    109.0 ± 14.0%
    Sources and values behind the range, same assay family
    ReportValueWhere
    Ben Haddou et al. 2014668 nMTable 2
    Toll et al. 1998317 nMTable 7
  • MethadoneAgonist980 nMToll et al. 1998
    Assay
    human DOR-CHO cell membranes, [35S]GTPgammaS binding
    Shown value from
    Toll et al. 1998, Table 7
    Error
    ± 99 SD
    Emax
    106.0 ± 21.0%

Mouse

1 measurement

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.